Cost and Accessibility: Is Compounded Cheaper
Semaglutide: The Breakthrough GLP-1 Semaglutide was the first GLP-1 drug to show double-digit percentage weight loss in large clinical trials
Non-acylated GLP-1RAs, such as exenatide, significantly penetrate the BBB and affect brain regions like the hypothalamus, which controls appetite
Checking lipase makes sense when there are symptoms (severe, persistent abdominal pain, often radiating to the back), not as a standing monitor
In the future, prices need to be reduced through mechanisms such as healthcare insurance negotiations and drug patent pools, and the development of biosimilar drugs should also be explored to expand the beneficiary population
The FDA has approved a handful of GLP-1 and dual GIP/GLP-1 medications for chronic weight management